Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Symbiosis00:58

Symbiosis

27.2K
Symbiotic relationships are long-term, close interactions between individuals of different species that affect the distribution and abundance of those species. When a relationship is beneficial to both species, this is called mutualism. When the relationship is beneficial to one species but neither beneficial nor harmful to the other species, this is called commensalism. When one organism is harmed to benefit another, the relationship is known as parasitism. These types of relationships often...
27.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elimination of gambiense human African trypanosomiasis as a public health problem in Republic of Guinea: Paving the way for zero transmission.

PLoS neglected tropical diseases·2026
Same author

[Characterization of imported dengue fever cases in Germany - Results of a pilot project].

Deutsche medizinische Wochenschrift (1946)·2026
Same author

Increase in imported mupirocin-resistant <i>Staphylococcus aureus</i> from the tropics and subtropics: trends in Berlin from 2018 to 2025.

New microbes and new infections·2026
Same author

Control of Human African Trypanosomiasis in the Nola-Bilolo Focus, Central African Republic, 2020-2024: Outcome of Capacity Building, Improved Diagnosis and Treatment.

Journal of parasitology research·2026
Same author

Imported Strongyloides stercoralis infections in Germany: descriptive study of cases over 5 years in a referral center in Berlin.

Travel medicine and infectious disease·2026
Same author

Targets of the human antibody response to the variant surface glycoprotein of <i>Trypanosoma brucei</i>.

bioRxiv : the preprint server for biology·2025
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026
Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026
See all related articles

Related Experiment Video

Updated: May 22, 2025

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.3K

Human African trypanosomiasis.

Veerle Lejon1, Andreas K Lindner2, Jose R Franco3

  • 1Intertryp, French National Research Institute for Sustainable Development, CIRAD, University of Montpellier, Montpellier, France.

Lancet (London, England)
|March 15, 2025
PubMed
Summary
This summary is machine-generated.

Human African trypanosomiasis (sleeping sickness) control has advanced with new diagnostics and the oral drug fexinidazole. These interventions, alongside vector control, aim to eliminate gambiense transmission by 2030.

More Related Videos

Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers Diethylaminoethyl-cellulose Columns
14:26

Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers Diethylaminoethyl-cellulose Columns

Published on: April 6, 2019

10.1K
Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis
07:59

Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis

Published on: May 18, 2016

7.7K

Related Experiment Videos

Last Updated: May 22, 2025

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

1.3K
Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers Diethylaminoethyl-cellulose Columns
14:26

Purification of Extracellular Trypanosomes, Including African, from Blood by Anion-Exchangers Diethylaminoethyl-cellulose Columns

Published on: April 6, 2019

10.1K
Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis
07:59

Bioluminescence Imaging to Detect Late Stage Infection of African Trypanosomiasis

Published on: May 18, 2016

7.7K

Area of Science:

  • Neglected tropical diseases
  • Parasitology
  • Public health

Background:

  • Human African trypanosomiasis (HAT), or sleeping sickness, is caused by Trypanosoma parasites transmitted by tsetse flies in sub-Saharan Africa.
  • Control strategies include case detection, treatment, and vector control.
  • Recent advancements include rapid diagnostic tests and new oral medications.

Purpose of the Study:

  • To review the progress and strategies for controlling Human African Trypanosomiasis.
  • To highlight the impact of new diagnostics and treatments on disease incidence.
  • To outline the goal of eliminating gambiense HAT transmission by 2030.

Main Methods:

  • Review of recent public health interventions for HAT control.
  • Analysis of the impact of rapid diagnostic tests and fexinidazole treatment.
  • Assessment of vector control methods, including tiny targets.

Main Results:

  • Significant reduction in HAT incidence achieved through medical interventions and vector control.
  • Fexinidazole established as a first-line oral treatment for both gambiense and rhodesiense HAT.
  • HAT has been eliminated as a public health problem in many areas.

Conclusions:

  • Improved diagnostics and therapeutics have substantially reduced HAT incidence.
  • Elimination of gambiense HAT transmission by 2030 is a targeted goal.
  • Sustained efforts involving multiple stakeholders are crucial for achieving HAT elimination.